Risk factor
Poor trading liquidity
Profitability factor
Very low or no dividends
About
SAMSUNG PHARM. Co., LTD. is a South Korean pharmaceutical company engaged in the manufacturing and distribution of a wide array of medical products. Its extensive portfolio includes a variety of prescription medications, encompassing treatments for conditions such as cancer (immunotherapy), pain, fever, and inflammation, obesity, high blood pressure, and arterial hardening, along with remedies for digestive disorders, phlegm, enzyme deficiencies, and osteoporosis. The company also supplies transfusion agents, skeletal muscle relaxants, antispasmodics, mixed vitamins, and antibiotics. Beyond these, SAMSUNG PHARM. provides general health and wellness products, including digestive aids, liver and circulatory system medications, cold remedies, nutritional supplements, health tonics, vitamins, energy drinks, and functional foods. Founded in 1929, the firm maintains its headquarters in Hwaseong-si, South Korea.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.